FDA Approved: METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE — Supplemental Application (KVK-Tech, Inc.)

View source ↗

Summary

The FDA-approved supplemental application approves a generic extended-release methylphenidate hydrochloride product from KVK-Tech, Inc. for ADHD and narcolepsy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder
• Narcolepsy

Drugs mentioned

• METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE (METHYLPHENIDATE HYDROCHLORIDE)

Snippet

SUPPL AP for METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE (METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE)